Seino Holdings Co., Ltd.
Seino Holdings Co., Ltd. (SEOTF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Seino Holdings Co., Ltd. (SEOTF), featuring income statements, balance sheets, and cash flow data.
Seino Holdings Co., Ltd. (SEOTF) Income Statement & Financial Overview
Analyze Seino Holdings Co., Ltd.’s SEOTF earnings with segmented quarterly and yearly financial statement figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $195.69B | $210.08B | $166.97B | $164.63B |
Cost of Revenue | $177.64B | $183.06B | $147.81B | $146.12B |
Gross Profit | $18.06B | $26.46B | $19.16B | $18.51B |
Gross Profit Ratio | $0.09 | $0.13 | $0.11 | $0.11 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $12.89B | $15.38B | $12.63B | $11.96B |
Operating Expenses | $12.89B | $14.82B | $12.63B | $12.49B |
Total Costs & Expenses | $190.52B | $198.44B | $160.44B | $158.09B |
Interest Income | $43.00M | $8.00M | $0.00 | $4.00M |
Interest Expense | $218.00M | $0.00 | $0.00 | $102.00M |
Depreciation & Amortization | $7.29B | $7.03B | $6.08B | $5.89B |
EBITDA | $15.72B | $18.67B | $12.61B | $12.44B |
EBITDA Ratio | $0.08 | $0.09 | $0.08 | $0.08 |
Operating Income | $5.17B | $11.64B | $6.53B | $6.55B |
Operating Income Ratio | $0.03 | $0.06 | $0.04 | $0.04 |
Other Income/Expenses (Net) | $3.03B | $1.43B | -$1.001B | -$846.00M |
Income Before Tax | $8.20B | $13.07B | $5.53B | $5.70B |
Income Before Tax Ratio | $0.04 | $0.06 | $0.03 | $0.03 |
Income Tax Expense | $2.59B | $4.70B | $2.29B | $2.55B |
Net Income | $5.06B | $7.76B | $3.24B | $3.19B |
Net Income Ratio | $0.03 | $0.04 | $0.02 | $0.02 |
EPS | $31.14 | $42.95 | $17.90 | $19.00 |
Diluted EPS | $28.85 | $42.95 | $17.99 | $17.66 |
Weighted Avg Shares Outstanding | $175.42M | $180.61M | $180.96M | $168.15M |
Weighted Avg Shares Outstanding (Diluted) | $175.42M | $180.61M | $180.007M | $180.92M |
Over the past four quarters, Seino Holdings Co., Ltd. demonstrated steady revenue growth, increasing from $164.63B in Q1 2024 to $195.69B in Q4 2024. Operating income reached $5.17B in Q4 2024, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $15.72B, reflecting operational efficiency. Net income dropped to $5.06B, with EPS at $31.14. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan